I now have comprehensive material from authoritative ENT textbooks. Let me compile the full 10-mark exam answer.
MS ENT Exam Answer (10 Marks)
PART A: Oro-Antral Fistula (OAF) as a Complication of Sinusitis
Definition
An oro-antral fistula (OAF) is an abnormal epithelialized communication between the oral cavity and the maxillary antrum (sinus). It may arise as a cause or a consequence of sinusitis.
Aetiology / Causes
Dental/Odontogenic (most common):
- Extraction of upper molar/premolar teeth (especially upper 1st and 2nd molars whose roots are in close proximity to the maxillary sinus floor)
- Periapical abscess of maxillary teeth
- Post-oral surgery infections (e.g., dental implant placement)
- Radical antral surgery (Caldwell-Luc)
- Endodontic treatment with overfilling (overfilled dental canal sealers can create an iatrogenic OAF and promote fungal colonization of the sinus)
Maxillary sinus disease:
- Chronic rhinosinusitis with odontogenic etiology
- Fungal sinusitis (fungi colonize via an OAF created during endodontic treatment)
Neoplastic:
- Maxillary antral carcinoma eroding the sinus floor, presenting through an OAF (Bailey & Love)
Traumatic: fractures of the alveolar ridge or hard palate
Pathophysiology
When a fistula exists, oral flora (including anaerobes) gain access to the sinus, causing odontogenic maxillary sinusitis. Conversely, chronic sinusitis leads to mucosal edema, osteitis of the sinus floor, and breakdown of the bony alveolar-antral barrier, perpetuating or enlarging an existing communication.
Clinical Features
- Passage of fluid/air from nose when drinking (regurgitation of fluid through the nose)
- Foul-smelling nasal discharge (cacosmia)
- Nasal obstruction; unilateral maxillary pain
- Food debris visible in the socket
- Valsalva test / nose-blowing test: air or saliva passes through the fistula into the nose
- CT scan: loss of maxillary sinus floor continuity; mucosal thickening or opacification of the antrum
Management of OAF
Acute (< 48-72 hours) - small defect < 2 mm:
- Spontaneous closure with clot formation
- Irrigate and pack the socket; prescribe antibiotics, nasal decongestants, and advise against nose-blowing
Surgical repair (for persistent/established fistulas):
-
Buccal advancement flap (Rehrmann flap): Most commonly used. A broad-based trapezoidal mucoperiosteal flap is elevated from the buccal sulcus and advanced to cover the defect. The periosteum is scored to allow tension-free closure.
-
Palatal rotation flap: A posteriorly based pedicled mucoperiosteal flap from the hard palate, rich in blood supply from the greater palatine artery. Useful for larger or posteriorly located defects. Leaves a raw donor area that heals by secondary intention.
-
Buccal fat pad flap: Used for moderate defects (up to 3x4 cm). The buccal fat pad is mobilized and sutured over the defect; it subsequently epithelializes.
-
For maxillary defects post-tumor ablation: Free flap reconstruction or prostheses with free tissue grafts (Sabiston Textbook; Bailey & Love).
Concurrent sinusitis management:
- Functional Endoscopic Sinus Surgery (FESS) with maxillary antrostomy to drain the infected sinus
- Involvement of oral maxillofacial surgery colleagues when odontogenic etiology is suspected (Scott-Brown Vol. 1)
- Prolonged antibiotics covering anaerobes (amoxicillin-clavulanate or metronidazole combination)
PART B: Management of Cavernous Sinus Thrombosis (CST)
Definition and Significance
CST is a potentially life-threatening intracranial complication of sinusitis (particularly ethmoid and sphenoid sinusitis) or dental infection. Mortality in adults is approximately 30-40% even with treatment. It accounts for ~9% of intracranial complications of acute rhinosinusitis. (Cummings Otolaryngology; Scott-Brown Vol. 1 & Vol. 2)
Pathophysiology
- Infection spreads from paranasal sinuses (ethmoid/sphenoid most implicated) or upper dentition via retrograde thrombophlebitis through the valveless ophthalmic venous system to the cavernous sinus
- Veins around the sinuses become congested and phlebitic during acute rhinosinusitis, with central propagation
- This causes septic thrombophlebitis of the cavernous sinus, leading to sepsis and multiple cranial nerve involvement (CN III, IV, V1, V2, VI)
- Common organisms: Staphylococcus aureus (most common, including MRSA), streptococci, gram-negative bacilli, and anaerobes; polymicrobial infection common in adults
Clinical Features
- Fever, lethargy, and systemic toxicity
- Retro-orbital / orbital pain (ophthalmic nerve neuralgia)
- Bilateral ptosis
- Proptosis and chemosis
- Complete ophthalmoplegia (involvement of CN III, IV, VI within the cavernous sinus)
- Dilated pupil with sluggish or absent pupillary light reflex
- Papilloedema
- Signs of meningeal irritation (neck stiffness, photophobia)
- Confusion and reduced level of consciousness (spiking fevers)
(Scott-Brown Vol. 2; Cummings; KJ Lee's Otolaryngology)
Investigations
- MRI brain with contrast (investigation of choice): Demonstrates dural enhancement in the region of the cavernous sinus; MR venography shows absence of flow in the thrombosed sinus (most sensitive)
- CT with IV contrast: May show filling defects equivalent to MRI; useful when MRI is not available
- Blood cultures: Before initiating antibiotics
- FBC, CRP, ESR, coagulation screen
- CSF analysis if meningitis is suspected (after excluding raised ICP)
- Microbiology liaison: Cultures and sensitivities to guide antibiotic choice
Management
1. Medical Management
A. Antibiotics (cornerstone of treatment):
- Broad-spectrum intravenous antibiotics must cover gram-positive cocci (especially S. aureus), gram-negative organisms, and anaerobes
- Recommended initial regimen: IV cephalosporin (e.g., cefotaxime or ceftriaxone) + metronidazole
- If MRSA is suspected: add vancomycin or linezolid
- Antibiotics must be continued for at least 2 weeks beyond clinical resolution because bacteria sequestered within the thrombus may not be killed until dural sinuses begin to recanalize
- Relapse of meningeal and ocular signs has been reported up to 6 weeks after cessation of antibiotics; follow-up for at least 6 months is advised (Scott-Brown Vol. 1)
B. Anticoagulation (controversial):
- No definitive consensus exists
- Arguments for: Anticoagulants prevent thrombus propagation and have anti-inflammatory properties
- Arguments against: Thrombus may wall off the infection; anticoagulants increase risk of intracranial hemorrhage in an inflammatory environment
- When used: start with unfractionated heparin (UFH) infusion, targeting APTT of 1.5-2x control; transition to low-molecular weight heparin (LMWH) once condition improves
- For aseptic CST: systemic anticoagulation (heparin followed by warfarin) or aspirin 325 mg daily is more clearly indicated (Wills Eye Manual; Harrison's Principles)
- For septic CST complicating bacterial meningitis with progressive neurological deterioration despite antimicrobial therapy: anticoagulation recommended (Harrison's 22E)
C. Steroids:
- Not routinely recommended
- Use only if there is evidence of pituitary insufficiency complicating CST (Scott-Brown Vol. 1)
D. Supportive care:
- Critical-care / ICU admission for life support and monitoring
- Intravenous fluid resuscitation
- Management of exposure keratopathy with lubricant eye drops/ointment
- Treatment of secondary glaucoma if present
2. Surgical Management
- Surgery is indicated only to drain any non-draining sinus infection or abscess collection - specifically the involved paranasal sinuses (ethmoid/sphenoid sinusotomy as relevant)
- FESS (functional endoscopic sinus surgery) with drainage of involved sinuses in a specialist neurosurgical centre
- No direct surgical decompression of the cavernous sinus is indicated
- Joint management with neurosurgeons in a specialist centre is mandatory (Scott-Brown Vol. 1 & Vol. 2)
Summary Table
| Aspect | OAF | Cavernous Sinus Thrombosis |
|---|
| Primary cause | Dental extraction, odontogenic infection | Ethmoid/sphenoid sinusitis, dental infection |
| Mechanism | Breakdown of sinus floor | Retrograde thrombophlebitis via ophthalmic veins |
| Key symptom | Nasal fluid regurgitation | Proptosis, ophthalmoplegia, fever |
| Investigation | CT sinus | MRI brain with contrast / MRV |
| Key treatment | Surgical flap closure + FESS | IV antibiotics x 2 wks post-resolution + ICU |
| Mortality | Negligible (morbidity only) | 30-40% |
Sources: Cummings Otolaryngology Head & Neck Surgery; Scott-Brown's Otorhinolaryngology HNS Vol. 1 & 2; KJ Lee's Essential Otolaryngology; Bailey & Love's Short Practice of Surgery 28th Ed.; Wills Eye Manual; Harrison's Principles of Internal Medicine 22E